Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by

Xin Li1, Xiangying Li1, Hongqiang Wang2

  • 1Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.

PubMed
Abstract

Insights

This study reveals pyroptosis genes are crucial in ankylosing spondylitis (AS) pathogenesis and immune microenvironment. Findings identify key pyroptosis genes for AS diagnosis and potential therapeutic targets, advancing understanding of this chronic inflammatory disease.

Area of Science:

  • Immunology
  • Genetics
  • Computational Biology

Background:

  • Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease with unclear pathogenesis, limiting diagnosis and treatment.
  • Pyroptosis, a pro-inflammatory cell death, is vital in immunity, but its role in AS remains unelucidated.

Purpose of the Study:

  • To investigate the relationship between pyroptosis-related genes (PRGs) and ankylosing spondylitis (AS).
  • To identify key PRGs for AS diagnosis and explore potential therapeutic strategies targeting pyroptosis pathways.

Main Methods:

  • Utilized GEO datasets (GSE73754, GSE25101, GSE221786) to identify differentially expressed PRGs (DE-PRGs) in AS.
  • Employed machine learning, PPI networks, WGCNA, and consensus clustering to screen key genes, construct diagnostic models, and classify AS subtypes.
  • Performed enrichment analysis (GO, KEGG), immune signature analysis (ESTIMATE, CIBERSORT), and drug prediction (CMAP) with molecular docking.

Main Results:

  • Identified 16 DE-PRGs in AS, correlating with immune cells like neutrophils and T cells.
  • Developed a diagnostic model using key genes (TNF, NLRC4, GZMB) with high AUC values (0.713-0.881) across datasets.
  • Classified AS patients into two subtypes with distinct immune infiltration patterns and identified potential drugs (ascorbic acid, RO 90-7501, celastrol) targeting GZMB.

Conclusions:

  • Pyroptosis plays a significant role in the immune microenvironment of AS.
  • The identified DE-PRGs and diagnostic model offer insights into AS pathogenesis and potential therapeutic interventions.
  • This research provides a foundation for further understanding and managing ankylosing spondylitis.